| Edit |   |
|---|
| Product Name | Bromocryptine (mesylate) |
|---|
| Description | Bromocriptine is a potent Cytochrome P450 3A inhibitor (~770 nM, see cat#K702). It also acts as a dopamine receptor agonist via the D2 receptor (Ki = 2.5 nM). As a result, it is used in combination therapy for Parkinsons disease. It also binds to the serotonin receptors 5-HT1A and 5-HT1D (Ki = 12.9 and 10.7 nM, respectively), as well as α and β adrenoreceptors and inhibits neuronal nitric oxide synthase (IC50 = 10 μM). MW: 750.7. Purity ≥98% |
|---|
| Size | 250 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (5α)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-errgotaman-3',6',18-trione, monomethanesulfonate, 2-Bromo-alpha-ergocryptine, CB-154, Parlodel, Cycloset |
|---|
| Gene, Accession, CAS # | CAS: 22260-51-1 |
|---|
| Catalog # | 2916-250 |
|---|
| Price | |
|---|
| Order / More Info | Bromocryptine (mesylate) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|